GlassScriptPhysician profile
Aliyah Suja
NPI 1285424002
$3,099.58
in general payments reported to CMS, 2019-2025
15 companies · $3,100 in 2025
The $3,100 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721 · Travel and Lodging: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.19 |
| Travel and Lodging | $1,378.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,820.08 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $316.20 | 2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $235.32 | 2025 | Arexvy, Nucala, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $215.89 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.25 | 2025 | Lifevest |
| Novo Nordisk INC | $117.36 | 2025 | Ozempic |
| Avadel Cns Pharmaceuticals, LLC | $46.16 | 2025 | Lumryz |
| Harmony Biosciences LLC | $36.51 | 2025 | |
| Genzyme Corporation | $34.56 | 2025 | |
| Axsome Therapeutics, INC. | $34.06 | 2025 | Sunosi |
| Verona Pharma, INC. | $28.44 | 2025 | Ohtuvayre |
| Shockwave Medical, INC | $24.81 | 2025 | |
| Merck Sharp & Dohme LLC | $20.05 | 2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.78 | 2025 | Jascayd |
| Viatris Specialty LLC | $15.11 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aliyah Suja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.